期刊文献+

伊托必利联合聚乙二醇在便秘患者结肠镜肠道准备中的效果 被引量:6

Combined use of Itopride and polyethylene glycol for colonoscopy preparation before endoscopy examination in constipated patients
下载PDF
导出
摘要 目的:观察伊托必利联合聚乙二醇在慢性便秘患者结肠镜检查前肠道准备的效果。方法:120例拟行结肠镜检查的慢性便秘患者随机分为治疗组和对照组。治疗组:在服用伊托必利150 mg半小时后。服用聚乙二醇:对照组:直接服用聚乙二醇。比较两组患者的肠道清洁效果、首次大便时间、大便清澈时间、大便次数、记录患者的不良反应。结果:治疗组患者肠道清洁度总体评分优于对照组(P<0.05);治疗组患者首次大便时间、大便清澈时间短于对照组(P<O.05);而两组间排便次数和肠道气泡评分差异无统计学意义(P>0.05)。结论:伊托必利联合聚乙二醇能安全、有效改善慢性便秘患者肠道准备的清洁度,缩短首次大便时间和大便清澈时间。 Objective:To investigate the effect of colonoscopy preparation before endoscopy examination in constipated patients combined use of Itopride and polyethylene glycol(PEG). Methods:A total of 120 chronic constipation patients who underwent colonoscopy examination were recruited to this randomized controlled study. Patients in control group received PEG only,whereas patients in experimental group received 150mg Itopride 30min before PEG. The quality of colon cleansing、time of first defecation、time of completion of bowel cleansing、defecation frequency were comparison and side effects were recorded in both group. Results: The bowel cleaning quality in experimental group was better than that of control group(P〈 0.05);The time of first defecation and completion of bowel cleaning of experimental group were shouter than those of control group (P〈0.05);There was no significant difference in terms of the defecation frequency and intestinal bubble scores in both groups( P〉0. 05).Conclusion: Combination of Itopride and PEG for colonoscopy preparation of patients with constipated can safely and effectively improve the bowel cleaning quality,short time of first defecation and completion of bowel cleaning.
出处 《广州医学院学报》 2014年第3期80-83,共4页 Academic Journal of Guangzhou Medical College
关键词 伊托必利 聚乙二醇 结肠镜 肠道准备 便秘 itopride hydrochloride polyethylene glycol colonoscopy bowel prepatation constipation
  • 相关文献

参考文献12

  • 1Oh SY,Sohn CI,Sung IK,et al. Factors affecting the technical difficulty of colonoscopy [ J ]. Hepatogastroenterology, 2007, 54(3) : 1403-1406.
  • 2Dipalma JA,Cleveland MV, McGowan J, et al. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation[J].Am J Gastroentem1,2010,(020 ) : 1436-1441.
  • 3Lai E J, Calderwood AH, Doros G, et al. Boston bowel preparation seale: a valid and reliable instrument for eolonoseopy-oriented research [ J ]. Gastrointest Endose, 2009,69(3) : 620-629.
  • 4Dipalma JA, Wolff BG, Mesgher A, et al. Comparison of reduced volume versus liters sulfate-free electrolyte lavage solutions for eolonoseoyt colon cleansing [ J ]. Am J Gastroenterol, 2003,98 (3) : 2187-2191.
  • 5Kim HN, Raju GS. Bowel preparation and colonoscopy technique to detect non-polypoid colorectal neoplasma[ J]. Gastrointest Endosc C|in N Am,2010,20(3) :47-48.
  • 6Belsey J, Crosta C, Epstein O, et al. Meta-analysis : the relative efficacy of oral bowel preparation for colonoscopy 1985-2010[ J]. Aliment Pharmacol Ther, 2012, 35 (3) : 222-237.
  • 7周丽雅,夏志伟,林三仁,王惠吉,于中麟,黄乃侠,吕宗舜,胡伏莲,陈宝雯,王化虹.聚乙二醇4000治疗成人慢性功能性便秘的多中心随机对照临床试验研究[J].中国临床药理学杂志,2001,17(1):7-10. 被引量:56
  • 8Lazarczyk DA, Stein AD, Courval JM, et al. Controlled study of cisapried-assisted lavage preparatory to colonoscopy[ J ]. Gastrointest Endosc, 1998,48 (3) : 44-48.
  • 9刘超,李延青.莫沙比利和聚乙二醇在肠镜检查前肠道准备中的联合应用价值研究[J].中华消化内镜杂志,2012,29(1):32-35. 被引量:33
  • 10Shenoy KT, Veenastee, Leena KB. Efficacy and tolerability of itopride ydrochloride in patients with non-ulcer dyspepsia[ J ]. J Indian Med Assoc, 2003,101 ( 3 ) : 387- 388.

二级参考文献29

  • 1[1]Dominguez-Munoz JE.Targeting the abnormalities of gastroduodenal functions in functional dyspepsia[J].Dig Dis,2001,19(3)∶195-200.
  • 2[2]Iwanaga Y,Miyashita N,Saito T,et al.Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs[J].Jpn J Pharmacol,1996,71(2)∶129-137.
  • 3[3]Iwanaga Y,Kimura T,Miyashita N,et al.Characterization of acetylcholinesterase-inhibition by itopride[J].Jpn J Pharmacol,1994,66(3)∶317-322.
  • 4[4]Harasawa S,Miwa T.Effect of itopride hydrochloride on gastric emptying in chronic gastritis patients[J].Jpn Pharmacol Ther,1993,11(21)∶4189-4195.
  • 5[5]Nakajima M,Uematsu T,Nakajima S.Phase I study of HSR-803[J].Jpn Pharmacol Ther,1993,11(21)∶4157-4173.
  • 6[6]Mushiroda T,Douya R,Takahara E,et al.The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride,a gastroprokinetic agent:comparison with cisapride and mosapride citrate[J].Drug Metab Dispos,2000,28(10)∶1231-1237.
  • 7[7]Miyoshi A,Omata S,Miwa T,et al.Clinical effect of HSR-803 on digestive symptoms:early phase Ⅱ study[J].Jpn Pharmacol Ther,1993,11(21)∶4175-4187.
  • 8[8]Miyoshi A,Masamune O,Sekiguchi T,et al.Clinical evaluation of itopride hydrochloride for gastrointestinal symptoms associated with chronic gastritis:multi-center double-blind clinical trial using cisapride as control drug[J].Jpn Pharmacol Ther,1994,12(4)∶261-279.
  • 9[9]Miyoshi A,Masamune O,Sekiguchi T,et al.Dose finding study of a gastroprokinetic agent,HSR-803,on gastrointestinal complations: late phase II study[J].Jpn Pharmacol Ther,1993,11(3)∶2107-2128.
  • 10[10]Hirakawa T,Yoshizawa M,Kagawa T,et al.Clinical effect of the peristalsis enhancer itopride hydrochloride on the digestive symptoms of chronic gastritis[J].Clinical Report,1993,15(27)∶5901-5906.

共引文献133

同被引文献59

引证文献6

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部